loadpatents
name:-0.025934934616089
name:-0.020459890365601
name:-0.01697301864624
UNIVERSITE DE LILLE 2 DROIT ET SANTE Patent Filings

UNIVERSITE DE LILLE 2 DROIT ET SANTE

Patent Applications and Registrations

Patent applications and USPTO patent grants for UNIVERSITE DE LILLE 2 DROIT ET SANTE.The latest application filed is for "compounds, pharmaceutical composition and their use in treating neurodegenerative diseases".

Company Profile
18.23.21
  • UNIVERSITE DE LILLE 2 DROIT ET SANTE - Lille FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds, Pharmaceutical Composition And Their Use In Treating Neurodegenerative Diseases
App 20210040034 - Melnyk; Patricia ;   et al.
2021-02-11
Novel 1,4-bis(3-aminopropyl)piperazine Derivative And Its Use
App 20200407325 - SERGEANT; Nicolas ;   et al.
2020-12-31
Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
Grant 10,844,008 - Melnyk , et al. November 24, 2
2020-11-24
1,4-bis(3-aminopropyl)piperazine derivative and its use
Grant 10,807,958 - Sergeant , et al. October 20, 2
2020-10-20
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imid- azol-2-amine, preparation thereof and use of the same
Grant 10,772,884 - Burlet , et al. Sept
2020-09-15
Light emitting system
Grant 10,561,856 - Mordon , et al. Feb
2020-02-18
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imid- azol-2-amine, preparation thereof and use of the same
Grant 10,537,569 - Burlet , et al. Ja
2020-01-21
SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMID- AZOL-2-AMINE, PREPARATION THEREOF A
App 20190381036 - BURLET; Stephane ;   et al.
2019-12-19
Optical fiber mode scrambler
Grant 10,401,567 - Mordon , et al. Sep
2019-09-03
Imidazol- or 1,2,4-triazol-derivatives and their use
Grant 10,323,016 - Charton , et al.
2019-06-18
Preparation Of Platelet Pellet Lysate And Its Use For Treating Neurological Disorders
App 20190099448 - DEVOS; David ;   et al.
2019-04-04
Compounds, Pharmaceutical Composition And Their Use In Treating Neurodegenerative Diseases
App 20190092721 - Melnyk; Patricia ;   et al.
2019-03-28
Optical Fiber Mode Scrambler
App 20190033525 - MORDON; Serge ;   et al.
2019-01-31
Pharmaceutical Solution Comprising Dopamine For Use In Treating Parkinson's Disease
App 20190022034 - Devos; David ;   et al.
2019-01-24
Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
Grant 10,179,761 - Melnyk , et al. Ja
2019-01-15
Pharmaceutical solution comprising dopamine for use in treating parkinson's disease
Grant 10,105,326 - Devos , et al. October 23, 2
2018-10-23
Novel 1,4-bis(3-aminopropyl)piperazine Derivative And Its Use
App 20180290981 - SERGEANT; Nicolas ;   et al.
2018-10-11
Artificial Root Canal Simulator Based On Hydroxyapatite
App 20180144661 - ROBBERECHT; Lieven ;   et al.
2018-05-24
2-oxo-3,4-dihydropyridine-5-carboxylates and their use
Grant 9,932,309 - Charton , et al. April 3, 2
2018-04-03
Novel 1,4-bis(3-aminopropyl)piperazine Derivative And Its Use
App 20180072679 - SERGEANT; Nicolas ;   et al.
2018-03-15
Multimeric Compounds Of A Kringle Domain From The Hepatocyte Growth Factor / Scatter Factor (hgf/sf)
App 20180008723 - VICOGNE; Jerome ;   et al.
2018-01-11
Met Receptor Agonist Proteins
App 20170369545 - VICOGNE; Jerome ;   et al.
2017-12-28
System For Treatment By Photodynamic Therapy And Method For Preparation Of Such System
App 20170348542 - BETROUNI; Nacim ;   et al.
2017-12-07
2-oxo-3,4-dihydropyridine-5-carboxylates And Their Use
App 20170210710 - Charton; Julie ;   et al.
2017-07-27
Carboline compounds usable in the treatment of neurodegenerative diseases
Grant 9,714,245 - Melnyk , et al. July 25, 2
2017-07-25
Imidazol- Or 1,2,4-triazol-derivatives And Their Use
App 20170190687 - Charton; Julie ;   et al.
2017-07-06
Method for functionalizing surfaces for analyte detection
Grant 9,671,397 - Melnyk , et al. June 6, 2
2017-06-06
Pharmaceutical Solution Comprising Dopamine For Use In Treating Parkinson's Disease
App 20170151193 - Devos; David ;   et al.
2017-06-01
SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMID- AZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME
App 20170151235 - BURLET; Stephane ;   et al.
2017-06-01
Compounds, Pharmaceutical Composition And Their Use In Treating Neurodegenerative Diseases
App 20170107174 - Melnyk; Patricia ;   et al.
2017-04-20
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imid- azol-2-amine, preparation thereof and use of the same
Grant 9,562,018 - Burlet , et al. February 7, 2
2017-02-07
Light Emitting System
App 20160220840 - MORDON; Serge ;   et al.
2016-08-04
Carboline Compounds Usable in The Treatment of Neurodegenerative Diseases
App 20160152610 - MELNYK; Patricia ;   et al.
2016-06-02
Medical Device, its Preparation Method and Applications Thereof
App 20160051832 - Mordon; Serge
2016-02-25
In vitro diagnostic test for enterovirus infections
Grant 7,534,558 - Chehadeh , et al. May 19, 2
2009-05-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed